Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1575 of 3173 entries
View as:

A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00990015 Org: User:
Start: 10/31/09 End: 01/31/10 Due: 01/31/11

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

Phase: N/A Priority: Normal
NCT ID: NCT00661765 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT01529671 Org: User:
Start: 01/31/12 End: 10/31/12 Due: 10/31/13

Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT02718677 Org: User:
Start: 09/01/19 End: 01/01/22 Due: 01/01/23

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01976364 Org: User:
Start: 02/17/14 End: 05/20/19 Due: 05/20/20

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04435769 Org: User:
Start: 08/04/20 End: 05/31/21 Due: 05/31/22

Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin

Phase: N/A Priority: Normal
NCT ID: NCT01127906 Org: User:
Start: 06/30/10 End: 09/30/10 Due: 09/30/11

A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01100060 Org: User:
Start: 04/30/10 End: 06/30/10 Due: 06/30/11

The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)

Phase: N/A Priority: Normal
NCT ID: NCT01189487 Org: User:
Start: 10/31/10 End: 04/30/11 Due: 04/30/12

Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06153758 Org: User:
Start: 11/27/23 End: 09/30/24 Due: 09/30/25

A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01488877 Org: User:
Start: 01/31/12 End: 07/31/12 Due: 07/31/13

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

Phase: N/A Priority: Normal
NCT ID: NCT02034916 Org: User:
Start: 12/13/13 End: 10/31/18 Due: 10/31/19

A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01146327 Org: User:
Start: 06/30/10 End: 01/31/11 Due: 01/31/12

A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

Phase: N/A Priority: Normal
NCT ID: NCT06448364 Org: User:
Start: 05/09/24 End: 08/15/24 Due: 08/15/25

A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03656952 Org: User:
Start: 09/05/18 End: 02/06/19 Due: 02/06/20

A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00566397 Org: User:
Start: 12/31/07 End: 12/31/10 Due: 12/31/11

A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product

Phase: N/A Priority: Normal
NCT ID: NCT00471224 Org: User:
Start: 06/30/07 End: 11/30/08 Due: 11/30/09

Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT01188655 Org: User:
Start: 05/31/08 End: 03/31/10 Due: 03/31/11

Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)

Phase: N/A Priority: Normal
NCT ID: NCT01190514 Org: User:
Start: 09/30/10 End: 11/30/10 Due: 11/30/11

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

Phase: N/A Priority: Normal
NCT ID: NCT01981473 Org: User:
Start: 01/31/14 End: 12/31/14 Due: 12/31/15

Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments

Phase: N/A Priority: Normal
NCT ID: NCT00560560 Org: User:
Start: 12/31/07 End: 09/30/10 Due: 09/30/11

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

Phase: N/A Priority: Normal
NCT ID: NCT01039688 Org: User:
Start: 01/31/10 End: 03/31/13 Due: 03/31/14

Study Of Sunitinib With FOLFIRI In Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00668863 Org: User:
Start: 05/31/08 End: 09/30/10 Due: 09/30/11

Multiple Dose Healthy Volunteer Safety Pharmacokinetics Study

Phase: N/A Priority: Normal
NCT ID: NCT00864786 Org: User:
Start: 09/30/08 End: 03/31/09 Due: 03/31/10

A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

Phase: N/A Priority: Normal
NCT ID: NCT00287066 Org: User:
Start: 02/28/06 End: 03/31/07 Due: 03/31/08